These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30009643)

  • 1. The mesentery: an ADME perspective on a 'new' organ.
    Argikar AA; Argikar UA
    Drug Metab Rev; 2018 Aug; 50(3):398-405. PubMed ID: 30009643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporters in absorption, distribution, and elimination.
    Scherrmann JM
    Chem Biodivers; 2009 Nov; 6(11):1933-42. PubMed ID: 19937831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesentery - a 'New' organ.
    Coffey JC; Walsh D; Byrnes KG; Hohenberger W; Heald RJ
    Emerg Top Life Sci; 2020 Sep; 4(2):191-206. PubMed ID: 32539112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
    Rodrigues AD; Rowland A
    J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics.
    Dalvie D
    Curr Pharm Des; 2000 Jul; 6(10):1009-28. PubMed ID: 10828299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box.
    Karlgren M; Simoff I; Keiser M; Oswald S; Artursson P
    Drug Metab Dispos; 2018 Nov; 46(11):1776-1786. PubMed ID: 30126863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of ADME evaluation in translation research of innovative drug].
    Liu Y; Hong L; Yu LS; Jiang HD; Chen JZ; Meng Q; Chen SQ; Zeng S
    Yao Xue Xue Bao; 2011 Jan; 46(1):19-29. PubMed ID: 21465804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
    Li M; Zou P; Tyner K; Lee S
    AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
    Fagerholm U
    Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the mesentery: structure, function, and role in disease.
    Coffey JC; Byrnes KG; Walsh DJ; Cunningham RM
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):96-106. PubMed ID: 34822760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
    Tsaioun K; Blaauboer BJ; Hartung T
    ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhRMA white paper on ADME pharmacogenomics.
    Williams JA; Andersson T; Andersson TB; Blanchard R; Behm MO; Cohen N; Edeki T; Franc M; Hillgren KM; Johnson KJ; Katz DA; Milton MN; Murray BP; Polli JW; Ricci D; Shipley LA; Vangala S; Wrighton SA
    J Clin Pharmacol; 2008 Jul; 48(7):849-89. PubMed ID: 18524998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomy of the mesentery: Historical development and recent advances.
    Byrnes KG; Walsh D; Lewton-Brain P; McDermott K; Coffey JC
    Semin Cell Dev Biol; 2019 Aug; 92():4-11. PubMed ID: 30316830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems-ADME/Tox: resources and network approaches.
    Ekins S
    J Pharmacol Toxicol Methods; 2006; 53(1):38-66. PubMed ID: 16054403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving early drug discovery through ADME modelling: an overview.
    Wishart DS
    Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesentery: structure, function, and role in disease.
    Coffey JC; O'Leary DP
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):238-247. PubMed ID: 28404096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.